SCHEMBL732828

SCHEMBL732828

Cn1nc(-c2ccccc2)c2ccc(C(=O)O)cc21

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.58
KDM4E B2RXH2 4/20 0.53
ALDH1A1 P00352 3/20 0.53
RORC P51449 4/20 0.51
SCN9A Q15858 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
NPC1 O15118 1/20 0.48
GAA P10253 1/20 0.48
RAB9A P51151 1/20 0.48
KMT2A Q03164 2/20 0.46
RARG P13631 1/20 0.45
HSD17B10 Q99714 2/20 0.44
MEN1 O00255 1/20 0.44
HTT P42858 1/20 0.44
CSNK2A2 P19784 1/20 0.44
CSNK2B P67870 1/20 0.44
TSHR P16473 1/20 0.44
PTGER1 P34995 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL121334 0.88 L3MBTL1 (0.59) HPGDKDM4EALDH1A1RORCL3MBTL1
SCHEMBL31632769 0.87 CSNK2A2 (0.50) HPGDKDM4EALDH1A1RORCSCN9A
SCHEMBL732982 0.86 ALDH1A1 (0.60) HPGDKDM4EALDH1A1SCN9AL3MBTL1
SCHEMBL31633183 0.83 CSNK2A2 (0.50) HPGDKDM4ERORCCSNK2A2CSNK2B
SCHEMBL31632881 0.82 RORC (0.52) HPGDKDM4EALDH1A1RORCSMN1; SMN2
SCHEMBL732894 0.81 RORC (0.50) HPGDKDM4EALDH1A1RORCSMN1; SMN2
SCHEMBL17306877 0.80 L3MBTL1 (0.51) HPGDKDM4EALDH1A1SCN9AL3MBTL1
SCHEMBL21725160 0.79 SLC22A12 (0.45) HPGDKDM4ERORCSCN9AHSD17B10
Acetic Acid SCHEMBL15622681 0.78 KMT2A (0.57) HPGDKDM4EALDH1A1RORCL3MBTL1
SCHEMBL4509480 0.78 SLC22A12 (0.57) KDM4EKMT2AMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2120569-B1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME (US) 2013-08-14 EP disclosed
EP-2120569-B1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME (US) 2013-08-14 EP disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
EP-2120569-A2 SPIROCHROMANON DERIVATIVES Merck & Co., Inc. (US) 2009-11-25 EP disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
WO-2008088692-A2 SPIROCHROMANON DERIVATIVES MERCK & CO., INC. (US) 2008-07-24 WO disclosed
WO-2008088692-A2 SPIROCHROMANON DERIVATIVES MERCK & CO., INC. (US) 2008-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270436-A1 SPIROCHROMANON DERIVATIVES AKR1C3, CBR3, AKR1C4 HPGD 2417/4885KDM4E 3445/4885ALDH1A1 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.